645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Hyo Han; Elizabeth Evans; Terrence Fisher; Hatem Soliman; Hung Khong; Aixa Soyano; Ricardo Costa; Loretta Loftus; Kimberley Lee; Avan Armaghani; Hien Liu; Frederick Locke; Alexandria Shrewsbury; Jessica Malka; Lavakumar Karyampudi; Maurice Zauderer; Brian Czerniecki

doi:10.1136/jitc-2022-SITC2022.0645

Citation Tools

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Han H, Evans E, Fisher T, et al

645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0645

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password